Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
McMullen & Hard was a historical New York-based brokerage firm and investment bank that operated during the mid-20th century. The firm was a member of the New York Stock Exchange (NYSE) and provided securities trading, investment advisory, and underwriting services. In 1978, the company merged into H.G. Wellington & Co., which later became part of Wellington Shields & Co. While the firm itself was not a life sciences company, it was involved in the financial markets during a period of significant industrial and pharmaceutical expansion, providing capital and investment services to various sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on McMullen & Hard.